Clarivate(CLVT)
icon
搜索文档
BioWorld by Clarivate Celebrates Nine Wins at 2024 APEX Awards
Prnewswire· 2024-07-18 15:00
Recognized for excellence in writing, news, mental health, financial/investment and economics categoriesLONDON, July 18, 2024 /PRNewswire/ -- BioWorld™ published by Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, has been honored with nine 2024 APEX Awards for Publication Excellence. This achievement underscores the BioWorld mission to deliver superior journalistic excellence, data-driven analysis and cutting-edge digital publishing.The APEX Awards, now in their 36th yea ...
Clarivate to Partner with OhioLINK and SearchOhio to Create a New Unified Library Experience Across the State of Ohio
Prnewswire· 2024-07-18 15:00
Bringing together Ohio's public and academic libraries' platforms to enhance and streamline customer-centric library resource sharing LONDON, July 18, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced a partnership with OhioLINK, Ohio's academic library consortium, and SearchOhio, a consortium of Ohio public libraries, to develop a new library resource sharing consortial experience.Through this partnership Clarivate will unify OhioLINK ...
Clarivate to Report Second Quarter 2024 Results on August 6, 2024
Prnewswire· 2024-07-16 21:00
LONDON, July 16, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today it will report its financial results for the second quarter 2024 before the market opens on Tuesday, August 6, 2024. The press release and earnings supplement, with accompanying financial information, will be available on the Clarivate investor website at https://ir.clarivate.com.The Company will host a conference call and webcast at 9:00 AM Eastern Time on Tuesday, Aug ...
Clarivate Annual G20 Scorecard Examines Global Research and Innovation Trends Across G20 Members
Prnewswire· 2024-07-16 15:00
Dynamic, interactive data visualizations reveal comprehensive view of the global research and innovation landscape LONDON, July 16, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today released its annual G20 scorecard, compiled by expert analysts and data scientists at the Institute for Scientific Information (ISI)™. The annual G20 research and innovation scorecard examines the research and innovation capabilities of each G20 member through dynamic ...
Clarivate Reveals First Year of Unitary Patent Court Litigation Activity
Prnewswire· 2024-07-10 16:00
Consistency in infringement cases with an average of ten filings per month LONDON, July 10, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today launched the report One year later in the UPC: First insights from Darts-ip™, which analyzes litigation data from the Unitary Patent Court's (UPC) inaugural year. The analysis sheds light on the future direction of the UPC and its continued role alongside the European national courts and other major global ...
Clarivate Identifies Six Breakthrough MedTech Trends in 2024 Set to Unlock New Industry Opportunities
Prnewswire· 2024-07-02 15:00
文章核心观点 - 医疗器械行业在经历了新冠疫情的影响后,正在经历一个关键的转折年[1][2] - 行业正在经历技术创新,如脉冲场消融和糖尿病护理等领域的进步,但同时也面临着经济不确定性、监管变化和供应链脆弱等挑战[2][4] - 行业需要适应这些动态,既要应对挑战,也要抓住新兴机遇,如人工智能在医疗器械中的应用以及门诊手术中心的增长[4][9] 行业趋势总结 服务地点的转变 - 为了跟上手术服务地点的变化,医疗器械公司需要调整销售和营销策略,适应不断扩大的非医院市场[4] - 传统的住院手术正在越来越多地转向门诊设置[4] GLP-1受体激动剂的影响 - GLP-1受体激动剂在减重应用中的初始采用给医疗器械行业带来了重大颠覆[5] - 尽管一些担忧有所缓解,但其对肥胖干预、美容和骨科等市场的长期影响仍存在不确定性[5] 医疗器械并购 - 整体来看,2024年医疗器械行业前景积极,大趋势如人口老龄化、医疗可及性提高和技术进步为创新和投资创造了条件[6] - 基于价值的医疗和数字生态系统的兴起有利于规模较大的公司,因为它们可以成为医疗系统的端到端合作伙伴[6] 供应链 - 行业供应链挑战阻碍了企业应对劳动力短缺、自然灾害和地缘政治冲突等外部压力的能力[7][8] - 近年来,特别是在新冠疫情之后,主要医疗器械公司一直在努力改善供应链,并继续战略性地投资于运营效率,以确保供应链的抗风险能力并最小化未来的影响[8] 人工智能在医疗器械中的应用 - 人工智能正在改变全球医疗技术,在内窥镜和诊断成像等领域革新实践[9] - 随着人工智能应用的扩展,它有望提高精度和患者结果,但需要在全球范围内应对不同的监管框架,确保安全和医疗卓越[9] 中国内地的监管变化 - 中国内地的带量采购(VBP)极大地影响了该国的市场和竞争格局[10] - 除了价格大幅下降及其对收入的影响,VBP的推出还促使跨国公司和国内企业在产品类别和地区的分阶段实施中调整其战略运营[10]
Clarivate Report Demonstrates Societal Impact of Digital Health Research and Innovation Growth
Prnewswire· 2024-06-27 18:15
LONDON, June 27, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today released a Global Research Report from the Institute for Scientific Information (ISI)™. The report integrates and interprets multiple data sources from across Clarivate™ portfolios to highlight the academic and societal benefits of the rapidly evolving landscape of digital health. Research impact in society and the economy: The digital health revolution in medical care highlights ...
Clarivate Launches IP Collaboration Hub
Prnewswire· 2024-06-24 15:00
文章核心观点 - 公司推出了IP Collaboration Hub™解决方案,旨在帮助用户在知识产权(IP)申请和诉讼过程中节省时间并降低风险 [1][2][3][4] - 该解决方案可以与公司的IP管理系统(IPMS)集成,为用户与全球代理商协作和交换信息提供一个中心枢纽,并自动记录所有信息 [2][4] - 该解决方案解决了IP行业过度依赖电子邮件进行沟通的关键问题,自动化和标准化了法律公司、企业与其当地代理商之间的沟通管理 [2][4] - 公司表示这是其更广泛战略的一部分,旨在成为IP管理的中心枢纽,包括扩展软件支持以及继续投资其领先的专利维护和IP管理软件(IPMS)功能 [3][4] 公司概况 - 公司是一家领先的全球转型情报提供商,在学术与政府、知识产权以及生命科学与医疗保健领域提供丰富的数据、见解和分析、工作流解决方案以及专业服务 [5]
Clarivate Reveals World's Leading and Trusted Journals with the 2024 Journal Citation Reports
Prnewswire· 2024-06-20 15:00
Adds Emerging Sources Citation Index™ for a simplified and unified category view LONDON, June 20, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today released the 2024 update to the Journal Citation Reports™ (JCR™). The reports provide an essential and comprehensive resource of high-quality journals, ranked by field to enable academic institutions, researchers and publishers to gauge the significance of journals in the global research landscape. Ch ...
Clarivate Identifies Seven Innovators in Antibody Drug Conjugates in New Companies to Watch Report
Prnewswire· 2024-06-19 15:00
Emerging standouts set to transform drug discovery and development, revolutionize cancer treatment, and capture big pharma interest highlighted in third annual report LONDON, June 19, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, has released its annual Companies to Watch report, highlighting seven innovative companies revolutionizing drug discovery and development. These companies are advancing antibody-drug conjugates (ADCs) to deliver highly tar ...